1. P190 Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with Quiescent Small Bowel Crohn's disease. (16th January 2018) Authors: Yablecovitch, D; Kopylov, U; Lahat, A; Amitai, M M; Klang, E; Ben-Ami Shor, D; Neuman, S; Levhar, N; Fudim, E; Avidan, B; Selinger, L; Orbach, N; Picard, O; Yavzori, M; Eliakim, R; Ben-Horin, S Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Tuftsin–phosphorylcholine (TPC) equally effective to methylprednisolone in ameliorating lupus nephritis in a mice model. (15th July 2018) Authors: Shemer, A; Kivity, S; Shovman, O; Bashi, T; Perry, O; Watad, A; Ben-Ami Shor, D; Volkov, A; Barshack, I; Bragazzi, N L; Krule, A; Fridkin, M; Amital, H; Blank, M; Shoenfeld, Y Journal: Clinical and experimental immunology Issue: Volume 193:Number 2(2018:Aug.) Page Start: 160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗